02617

6.4504.30%
DW

Di Wu

President, Financial Controller & Executive Director

Mr. Di Wu served as VP and serves as Financial Controller & Executive Director of TransThera Sciences (Nanjing), Inc. (formerly known as Nanjing TransThera Biosciences Co. Ltd.) from March 16, 2020. He serves as President of TransThera Sciences (Nanjing), Inc. Mr. Wu joined the TransThera Sciences (Nanjing), Inc. (formerly known as Nanjing TransThera Biosciences Co. Ltd.) on January 13, 2017 and has been responsible for its financial operation and management as well as strategy and business development since then. Prior to joining TransThera Sciences (Nanjing), Inc., Mr. Wu was the business development director of Shandong Xuanzhu Biopharmaceutical, a pharmaceutical R&D company and he was responsible for the international business development from January 2015 to January 2017. And before that, he was also employed as a regular full-time employee at Boehringer Ingelheim Pharmaceuticals Inc., a company primarily engaged in a U.S. corporation principally engaged in scientific research in order to develop and market ethical pharmaceuticals until January 2015. Mr. Wu obtained his bachelor?s degree in science from the Peking University in the PRC in July 2001. He further obtained his master?s degree in science from the University of Nebraska in the U.S. in July 2005. He also obtained another master?s degree in business administration in the New York University in the U.S. in September 2015.

Positions